Appili Therapeutics Inc (APLIF) Financials
APLIF Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| June 30, 2026 | 912032 | 14.3 million |
| March 31, 2026 | 1.4 million | 13.9 million |
| Dec. 31, 2025 | 399323 | 12.3 million |
| Sept. 30, 2025 | 541832 | 11.7 million |
APLIF Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| June 30, 2026 | ? | ? |
| March 31, 2026 | -190506 | 7615 |
| Dec. 31, 2025 | -213590 | 8094 |
| Sept. 30, 2025 | -545364 | 8313 |
APLIF Net Income
No data available :(
APLIF Cash and Debt
Graph available only for paid members. Upgrade to see it.
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| June 30, 2026 | 97649 | 450861 | - |
| March 31, 2026 | 28760 | 482790 | - |
| Dec. 31, 2025 | 155055 | 536984 | - |
| Sept. 30, 2025 | 250412 | 437368 | - |
APLIF Shares Outstanding
APLIF Expenses
Graph available only for paid members. Upgrade to see it.
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| June 30, 2026 | 26032 | 494967 | 723445 | - |
| March 31, 2026 | 2 | 1.4 million | 439522 | - |
| Dec. 31, 2025 | - | 419308 | 187271 | - |
| Sept. 30, 2025 | - | 602082 | 405213 | - |
APLIF Cost of Revenue
Graph available only for paid members. Upgrade to see it.
| Date | Revenue | Cost of Revenue |
|---|---|---|
| June 30, 2026 | 83013 | 951 |
| March 31, 2026 | 30193 | 970 |
| Dec. 31, 2025 | 83798 | -92 |
| Sept. 30, 2025 | 74643 | 2333 |
APLIF
Price: $0.01
52 week price:
Earnings Per Share: -0.02 USD
Exchange: PNK
Sector: Healthcare
Industry: Biotechnology
Market Capitalization: 529464